Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications


Welcome Nano-OligoMed


The MSCA-RISE-2017 – Research and Innovation Staff Exchange Nano-OligoMed Project. Is a collaborative network which aims to generate new useful nanostructured oligonucleotide carriers by hybridization with the most promising nanostructured systems with biomedical applications.  It brings together the expertise of seven groups based on France, Italy, Spain, US, Cuba and Canada. 

The project is funded by the European Commission through the Marie Skłodowska-Curie actions.

© Nano-OligoMed MSCA-RISE-778133

European Commission

Horizon 2020


Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

Marie Skłodowska-Curie Actions

Research and Innovation Staff Exchange

The RISE scheme promotes international and cross-sector collaboration through exchanging research and innovation staff, and sharing knowledge and ideas from research to market (and vice-versa).

The scheme fosters a shared culture of research and innovation that welcomes and rewards creativity and entrepreneurship and helps to turn creative ideas into innovative products, services or processes.

Secondment Months